BioMed Research International

BioMed Research International / 2019 / Article

Retraction | Open Access

Volume 2019 |Article ID 8195729 | 1 page | https://doi.org/10.1155/2019/8195729

Retracted: Recent Trends of Polymer Mediated Liposomal Gene Delivery System

Received03 Jul 2019
Accepted03 Jul 2019
Published08 Aug 2019

BioMed Research International has retracted the article titled “Recent Trends of Polymer Mediated Liposomal Gene Delivery System” [1]. The article was found to contain a substantial amount of material from a number of published articles, including the following sources:

(i) L. E. van Vlerken, T. K. Vyas, and M. M. Amiji, “Poly(ethylene glycol)-Modified Nanocarriers for Tumor-Targeted and Intracellular Delivery,” Pharmaceutical Research, vol. 24, no. 8, pp. 1405–1414, 2007, https://doi.org/10.1007/s11095-007-9284-6 [2] (cited as ).

(ii) Daniel A. Balazs and WT. Godbey, “Liposomes for Use in Gene Delivery,” Journal of Drug Delivery, vol. 2011, Article ID 326497, 12 pages, 2011, https://doi.org/10.1155/2011/326497 [3] (not cited).

(iii) Vladimir P. Torchilin, “Recent Advances with Liposomes as Pharmaceutical Carriers,” Nature Reviews Drug Discovery, vol. 4, no. 2, pp. 145–160, 2005, https://doi.org/10.1038/nrd1632 [4] (cited as ).

(iv) Arcadio Chonn and Pieter R Cullis, “Recent Advances in Liposome Technologies and Their Applications for Systemic Gene Delivery,” Advanced Drug Delivery Reviews, 1998, https://doi.org/10.1016/S0169-409X(97)00108-7 [5] (not cited).

(v) Marika Ruponen, Seppo Ylä-Herttuala, and Arto Urtti, “Interactions of Polymeric and Liposomal Gene Delivery Systems with Extracellular Glycosaminoglycans: Physicochemical and Transfection Studies,” Biochimica et Biophysica Acta: Biomembranes, vol. 1415, no. 2, pp. 331–341, 1999, https://doi.org/10.1016/S0005-2736(98)00199-0 [6] (cited as ).

The authors do not agree to the retraction.

References

  1. S. K. Kundu, A. R. Sharma, S. S. Lee et al., “Recent trends of polymer mediated liposomal gene delivery system,” BioMed Research International, vol. 2014, Article ID 934605, 15 pages, 2014. View at: Publisher Site | Google Scholar
  2. L. E. van Vlerken, T. K. Vyas, and M. M. Amiji, “Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery,” Pharmaceutical Research, vol. 24, no. 8, pp. 1405–1414, 2007. View at: Publisher Site | Google Scholar
  3. D. A. Balazs and W. T. Godbey, “Liposomes for use in gene delivery,” Journal of Drug Delivery, vol. 2011, Article ID 326497, 12 pages, 2011. View at: Publisher Site | Google Scholar
  4. K.-L. Kuo and D.-C. Tarng, “Oxidative stress in chronic kidney disease,” Adaptive Medicine, vol. 2, no. 2, pp. 87–94, 2010. View at: Google Scholar
  5. A. Chonn and P. R. Cullis, “Recent advances in liposome technologies and their applications for systemic gene delivery,” Advanced Drug Delivery Reviews, vol. 30, no. 1-3, pp. 73–83, 1998. View at: Publisher Site | Google Scholar
  6. M. Ruponen, S. Ylä-Herttuala, and A. Urtti, “Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1415, no. 2, pp. 331–341, 1999. View at: Publisher Site | Google Scholar

Copyright © 2019 BioMed Research International. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

433 Views | 233 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.